Related Experiment Video
Updated: Aug 14, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Abstract:
There is increasing awareness that the toxicity of many xenobiotics is mediated through the production of active metabolites. The enzyme system most involved in the production of active metabolites would appear to be the cytochrome P-450-dependent microsomal mixed function oxidase (MFO) system, although other enzyme systems may be important in particular instances. The routes of metabolic activation invariably occur alongside, or prior to, opposing inactivation pathways and the rate and extent of production of the active metabolite depends upon the balance of activation/inactivation pathways. The main site of activation of xenobiotic nongenetic toxins would appear to be the liver, whether for hepatic or extra-hepatic toxins, but extra-hepatic activation may also be important for certain extra-hepatic toxins. This awareness of the role of metabolic activation has led to the introduction of various activation systems into tissue culture toxicity studies. However, this use of activation systems should be carefully considered in relation to the proposed use of the tissue culture toxicity study. Thus, if it is intended to study organ-specific toxicity using tissue cultures, then it is essential that the cultured cells retain the ability to activate the relevant organ-specific toxins. The activation systems that have been reported include the whole animal, intact liver cells and liver microsomes. Examples are given to illustrate the relative merits of these systems and the different but nevertheless complementary information that can be gained from use of a number of different activation systems.
Insights
Metabolic activation, primarily by cytochrome P-450 enzymes, generates toxic metabolites. Understanding the balance of activation and inactivation pathways is crucial for assessing xenobiotic toxicity, especially in tissue culture studies.
Area of Science:
- Toxicology
- Drug Metabolism
- Biochemistry
Background:
- Xenobiotic toxicity is often mediated by active metabolites.
- The cytochrome P-450-dependent microsomal mixed function oxidase (MFO) system is a key player in producing these metabolites.
- Metabolic activation pathways are balanced by inactivation pathways, influencing the extent of toxicity.
Purpose of the Study:
- To review the role of metabolic activation in xenobiotic toxicity.
- To discuss the use and considerations of activation systems in tissue culture toxicity studies.
- To evaluate different activation systems for their merits in toxicity assessment.
Main Methods:
- Review of existing literature on xenobiotic metabolism and toxicity.
- Discussion of various in vitro and in vivo activation systems.
- Comparative analysis of different activation systems (whole animal, liver cells, microsomes).
Main Results:
- Metabolic activation is a critical determinant of xenobiotic toxicity.
- The liver is a primary site for xenobiotic activation, but extra-hepatic sites are also relevant.
- Different activation systems provide complementary information for toxicity studies.
Conclusions:
- Careful selection of activation systems is essential for accurate tissue culture toxicity studies, especially for organ-specific toxicity.
- The choice of activation system should align with the study's objectives.
- Utilizing multiple activation systems can yield comprehensive insights into xenobiotic toxicity.
Related Concept Videos
Mutagenicity and Carcinogenicity
Bioactivation and Tissue Toxicity
Toxicity Testing in Animals

